Warning letter
Biological Controls [ARCHIVED]: warning letter of Feb 16, 2010
FDA warning letter 94566 · New Jersey District Office
Key facts
| Reference number | 94566 |
|---|---|
| Company | Biological Controls [ARCHIVED] |
| Subject | CGMP/QSR/Adulterated/Misbranded |
| Issue date | Feb 16, 2010 |
| Posted date | Feb 16, 2010 |
| Issuing office | New Jersey District Office |
| Product type | Devices |
| CFR sections cited | 820, 820.40 |
| Inspection city | Eatontown |
| Inspection ZIP | 07724 |
| Inspection start date | Nov 17, 2009 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: